Abstract
Over a 4-year period 35 patients with mid- (15 patients) and low (20 patients) rectal cancer clinically staged as T2 N1-2, T3 N0-2 underwent a protocol of combined surgery and radiotherapy. The protocol included: preoperative external beam radiotherapy (38 Gy, ICRU50); surgical resection; IORT on tumor bed (10 Gy). Toxicity of preoperative treatment was mild with a single case (2.9%) of grade 3 gastrointestinal toxicity. 18 patients underwent anterior resection and 17 abdominoperineal resection. Perioperative mortality and morbidity were 0% and 17.1% respectively. At a mean follow-up of 25 months all patients were alive. The single anastomotic recurrence observed was rescued with abdominoperineal resection.
| Original language | English |
|---|---|
| Pages (from-to) | 190-196 |
| Number of pages | 7 |
| Journal | RAYS |
| Volume | 20 |
| Publication status | Published - 1995 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Endoscopy
- Follow-Up Studies
- Humans
- Intraoperative Care
- Neoplasm Recurrence, Local
- Preoperative Care
- Rectal Neoplasms
- Risk Factors
- Time Factors
Fingerprint
Dive into the research topics of 'Preoperative radiotherapy and IORT in resectable rectal cancer at high risk for local recurrence'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver